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Abstract 
 Electrons can migrate via proteins over distances that are considered long for non-
conjugated systems. Proteins’ nano-scale dimensions and the enormous flexibility of their 
structures and chemistry makes them fascinating subjects for investigating the mecha-
nism of their electron transport (ETp) capacity. One particular attractive research direc-
tion is that of tuning their ETp efficiency by doping them with external small molecules. 
Here we report that solid-state ETp across human serum albumin (HSA) increases by 
more than two orders of magnitude upon retinoate (RA) binding to HSA. RA was chosen 
because optical spectroscopy has provided evidence for the non-covalent binding of at 
least three RA molecules to HSA and indications for their relative structural positions. 
The temperature dependence of ETp shows that both the activation energy and the dis-
tance-decay constant decrease with increasing RA binding to HSA. Furthermore, the ob-
served transition from temperature-activated ETp above 190K to temperature-
independent ETp below this temperature suggests a change in the ETp mechanism with 
temperature. 
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Bridging the worlds of biology and solid-state electronics presents a fascinating chal-
lenge.
[1]
 One approach to achieve this is exploring the use of biomolecules as electron 
transport (ETp) materials.
[1b]
 Indeed, diverse biological macromolecules, from proteins,
[2]
 
peptides,
[3]
 to DNA,
[4]
 and peptide-nucleic acids
[5]
 have been studied as such, using scan-
ning probe (conductive-probe atomic force or scanning-tunneling) microscopy or meas-
urements via molecules, sandwiched between macroscopic electrodes.
[1b, 2a, 2c-e, 6]
 Most 
studied proteins are those with biological electron transfer (ET) function, such as 
azurin,
[2c, 2e, 7]
 cytochrome C
[6, 8]
 or plastocyanin.
[9]
 We have recently shown, using mac-
roscopic contacts, that bacteriorhodopsin (bR), a protein that does not have a natural ET 
function, but contains the covalently bound cofactor retinal, has a room temperature ETp 
efficiency similar to that of ET proteins.
[2c, 10]
 However, proteins devoid of any cofactor, 
such as apo-azurin, serum albumin, as well as washed apo-bR, exhibit an order of magni-
tude lower ETp efficiency than, e.g., the ET protein azurin.
[2c, 7b]
  
Here we show that ETp via human serum albumin (HSA), a protein that lacks any co-
factor, increases by over 2 orders of magnitude upon binding non-covalently (doping 
with) 3 equivalents of deprotonated retinoic acid, i.e., retinoate, (RA). RA is a close de-
rivative of the bR cofactor (retinal), and has a biological role in the growth and develop-
ment of the embryo.
[11]
 We chose to study HSA, because of its extraordinary binding ca-
pacity of small, mainly hydrophobic, molecules.
[12]
 We used the all-trans isomer of RA, 
due to its relatively high affinity to HSA, with an aneraged binding constant of 3.3·10
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M
-1
, and as it has no known effect on the proteins’ conformation.[13] HSA has been sug-
gested to bind up to three equivalents of RA,
[13]
 but as no three-dimensional structure of 
an HSA-RA complex is available, the locations of the RA binding sites within HSA are 
not agreed on. Kossi et al.
[13b]
 suggested that RA binding sites are those, known for long-
chain fatty acids.
[14]
 Maiti et al.
[13d]
 proposed, based on molecular dynamics docking sim-
ulations, one hydrophobic site between subdomains IIA and IIIA, while Belatik et al.
[13e]
 
suggested the site of subdomain IB (one of the binding sites for long-chain fatty acids) to 
be the main RA binding site (cf. Fig. S1 in the supporting information).  
The addition of RA (stock solution in ethanol) to HSA (aqueous PBS buffer, pH 8) 
leads to its binding, which can be monitored by UV-Vis absorption spectroscopy.
[13]
 As 
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illustrated in Fig. 1, a gradual increase in absorption is observed (max=346 nm, ascribed 
to retinoate
[13c]
) as the ratio of ligand to protein (L/P), i.e., RA/HSA, was increased, sug-
gesting RA-HSA complex formation. As also seen in the figure, at L/P = 4, a second 
band (at ~405 nm), red-shifted from the main band (346 nm) appears. This second band 
is ascribed to retinoic acid.
[13c]
 The increase in the 346 nm band intensity at L/P = 4 sug-
gests that a fourth RA might bind to HSA, but due to the appearance of the second ab-
sorption band at ~405 nm we can conclude that the pKa of this binding site is somewhat 
increased in comparison to the other binding sites. However, and more important to the 
scope of this communication (as will be shown later), the fourth equivalent hardly affects 
the ETp characteristics. Further evidence for retinoate being the main bound species to 
HSA is derived from the absorption spectra of RA-HSA complexes with different L/P 
ratios at different pH values (Fig. S2, and supplemental text), which show lower absorp-
tion at low pH’s (pH = 6-7) than at high pH’s (pH = 8-9).  
Monolayers of HSA alone and of its complexes with RA at different L/P ratios were 
prepared on a Si surface for ETp measurements. The used protocol was the same as that 
previously employed for studies of bovine serum albumin (BSA).
[2c]
 The similarity of 
surface coverage by HSA at different L/P ratios was verified optically by ellipsometry, 
yielding an optical thickness of 17-20 Å. In addition, atomic force microscopy indicated 
similar surface morphology of the different surfaces (Fig. 2a), comparable to that found 
for surfaces of BSA monolayers (Fig. S3).
[2c]
  
While surface coverage and morphology with different L/P were similar, the ETp effi-
ciency at room-temperature (Fig. 2b) showed up to a nearly 2 orders of magnitude in-
crease with increasing equivalents of bound RA. The main increase (an order of magni-
tude) was observed upon binding the third equivalent, while addition of the fourth one 
only gave a small further increase.  
To investigate the ETp mechanism we studied the change in the current density as a 
function of temperature (Fig. 3a). As seen in the figure, all curves exhibit a temperature-
independent regime at low temperatures (<190K), and a thermally activated regime at 
higher temperatures (≥190K). The magnitude of the current densities and their change as 
a function of temperature are quite similar for HSA and BSA (Fig. S4). The current den-
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sities across the proteins can be presented by different expressions, for the temperature-
independent regime, JTI, and for the thermally activated regime, JTA:
[10, 15]
 
                                      (1) 
where β is the distance-decay constant of ETp, l is the geometrical separation of the elec-
trodes across which ETp takes place, Ea is the activation energy for the thermally activat-
ed ETp, kB is the Boltzmann constant and T is the absolute temperature. The dominant 
process at a certain temperature determines the measured current density. We will now 
discuss the effect of binding RA to HSA on ETp in these two regimes. 
At low temperatures, where JTI dominates, we find a ~330 fold increase in current den-
sities for the HSA complex with three RA equivalents compared to those of HSA alone. 
The left proportionality of Eq. 1 implies that the change in the current density can be ex-
plained by either a change in β (assuming that the distance between the electrodes re-
mains the same) or by the pre-exponential factor (not shown in the proportionality), 
which refers to the coupling matrix of the ETp process via the electrode-protein-electrode 
system. While we cannot estimate the change in the coupling matrix, the similarity in the 
junction configurations and the constant separation distance between the electrodes fa-
vors β as the main parameter that changes. With this assumption the increase in tempera-
ture-independent current densities can be expressed as a result of a decrease in β values:  
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.                         (2) 
Here H is the coupling matrix, JTI,n and βn are the current density in the temperature-
independent regime and the distance-decay constant at L/P = n, respectively. For the cal-
culation we took the thickness of the protein monolayer (perpendicular to the surface), 
i.e., the maximal distance across which ETp occurs, to be ~37 Å, as determined by the 3-
dimensional structure of the protein (PDB ID: 1E7I, Fig. S5), and also illustrated by the 
z-axis of the AFM image (Fig. 2a). In a similar way we can calculate that β2 = β0 - 0.07 
and β1 = β0 - 0.05. We assume that in this temperature regime ETp occurs by resonant 
tunneling, provided by the bound RA, and even more so that of several proximally bound 
exp( )TIJ l  exp( / )TA a BJ E k T 
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RAs, within HSA. The presence of RA lowers the energy levels, involved in the ETp 
process, similar to what is observed in redox proteins,
[16]
 explaining the decrease in β 
values.  
Binding RA to HSA also affects the ETp behavior in the high-temperature regime, 
where thermally activated ETp is observed (current density described by JTA, as in eq. 1), 
with clear differences in the currents’ temperature dependence at different L/P ratios. 
Plots of ln(JTA) vs. T
-1
 are linear (Arrhenius plots; Fig. 3b) and show that the activation 
energy, Ea, decreases as L/P increases. Here, too, it is reasonable to assume that the intro-
duction of several RAs lowers the energy barriers for the non-adiabatic ETp process, cor-
responding to shallower diabatic curves and lower reorganization energies, which, conse-
quently cause a decrease in the observed activation energy.  
The large increase in current density through the protein monolayer as a function of 
RA binding is remarkable, especially because the doped protein has no known electron or 
charge transfer role in nature. This emphasizes the crucial role of any bound cofactor in 
the ETp via proteins. It also suggests that the structure of a protein can serve as frame-
work for efficient ETp, upon binding an appropriate cofactor, irrespective of the protein’s 
natural function. In this context, we note that the current density (at 0.05 V) through the 
doped HSA monolayer (at L/P = 3) is even slightly higher, especially in the low-
temperature regime, than through bR, a natural retinal-containing protein,
[10]
 or through a 
natural ET protein, azurin.
[7b]
  
In conclusion, we discovered that the ETp via a solid-state monolayer of HSA increas-
es dramatically as a result of HSA doping with up to 3 equivalents of RA. The increase in 
ETp with increasing L/P can be interpreted as a change in ETp parameters. This change is 
expressed as a decrease both in the distance-decay constant of the temperature-
independent ETp at low temperatures, and in the activation energy of the temperature de-
pendent ETp at higher temperatures. The drastic increase in currents by RA-doping of 
HSA confirms and significantly extends our earlier tenet that proteins can behave as mo-
lecular wires, upon cofactor binding. The ability to markedly enhance the electrical con-
ductivity of a protein monolayer over a significant range may be of interest for using pro-
teins as ETp mediators in future bio-electronics devices.  
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Figure 1. Optical UV-Vis absorption spectra of HSA and RA at different L/P ratios at 
pH=8.  
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Figure 2. Solid state monolayer on Si substrate. (a) AFM image of an HSA monolayer 
surface. Z-scale is 4.5 nm; the rms roughness is centered at 1.7 nm. (b) Current density-
voltage curves of HSA-RA complexes with L/P = 0 - 4, at room temperature. 
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Figure 3. ETp temperature dependence. (a) current density at -50 mV as a function of 
temperature over the range of 20-340 K. (b) zoom of (a) in the thermally-activated re-
gime (230-340K), showing also the calculated activation energies for each L/P ratio. 
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Figure S1. The structure of HSA (PDB: 1E7I) with its sub-domains, along with the dif-
ferent suggested RA binding sites (references are given in the picture). 
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Figure S2. Optical UV-Vis absorption spectra of HSA and RA at Different pH's (pH 6-9) 
at L/P = 1, 2, 3 and 4, (a) – (d) respectively. 
 
Binding of retinoate to HSA 
Figure S2 shows the lower absorption of RA (or retinoic acid) in the presence of HSA at 
low pH’s (pH = 6-7) than at high pH’s (pH = 8-9). Another indication for inefficient 
binding at pH = 6-7 is that already upon addition of the first RA equivalent a turbid yel-
lowish solution results, whereas at pH = 8-9 the solution remains clear up to L/P = 3. The 
observation that retinoate binds to HSA, supports the binding sites location proposed pre-
viously,
[1]
 since these binding sites include positively charged amino acids, which will 
enable retinoate binding via electrostatic interaction. As the optical absorption spectra of 
RA binding to HSA do not allow for distinguishing between the different RA binding 
sites, we cannot exclude the possibility of having a mixture of proteins with L/P ratio, 
different from that of the solution. 
 
200 300 400 500 600 700 800
0.00
0.02
0.04
0.06
0.08
0.10
200 300 400 500 600 700 800
0.00
0.02
0.04
0.06
0.08
0.10
0.12
200 300 400 500 600 700 800
0.00
0.03
0.06
0.09
0.12
0.15
200 300 400 500 600 700 800
0.00
0.05
0.10
0.15
0.20
0.25
 
 
 pH6
 pH7
 pH8
 pH9
L/P=1 L/P=2
 
 
L/P=3
A
b
s
o
rp
ti
o
n
 (
O
.D
)
Wavelength (nm)
 
 
L/P=4
 
 
(a) (b) 
(c) (d) 
14 
 
 
F 
 
 
 
 
 
 
 
 
 
 
Figure S3. Comparison of the surface morphology, as measured by AFM, between BSA 
(top image, taken from ref. 2c) and HSA (bottom image). 
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Figure S4. Comparison of the current density (at -0.05V) as a function of temperature via 
BSA (taken from ref. 7b) and via HSA monolayers. 
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Figure S5. Top image: the short axis of HSA, which assumed to be the thickness of the 
monolayer (the protein is perpendicular to the surface). Bottom image: the long axis of 
HSA.  
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